Accelerated thyrotoxicosis induced by iodinated contrast media in metastatic differentiated thyroid carcinoma

Journal of Nuclear Medicine

Volumn 37, Issue 9, 1996, Pages 1532-1535

  Lorberboym, Mordechai ^a   Mechanick, Jeffrey I ^a  

^a MOUNT SINAI MEDICAL CENTER   (United States)

Author keywords

granulocyte colony stimulating factor; thyroid carcinoma; thyrotoxicosis

Indexed keywords

GRANULOCYTE COLONY STIMULATING FACTOR; IODINATED CONTRAST MEDIUM; IODINE 131; RADIOACTIVE IODINE; THALLIUM 201;

AGED; ARTICLE; BONE METASTASIS; CANCER DIAGNOSIS; CANCER PALLIATIVE THERAPY; CANCER RADIOTHERAPY; CASE REPORT; FEMALE; HUMAN; HYPERTHYROIDISM; PELVIS TUMOR; PRIORITY JOURNAL; THYROID FOLLICULAR CARCINOMA; THYROTOXICOSIS; WHOLE BODY SCINTISCANNING;

ADENOCARCINOMA, FOLLICULAR; AGED; CHORISTOMA; CONTRAST MEDIA; FEMALE; HUMANS; IODINE; IODINE RADIOISOTOPES; PELVIC NEOPLASMS; THALLIUM RADIOISOTOPES; THYROID GLAND; THYROID NEOPLASMS; THYROIDECTOMY; THYROTOXICOSIS;

EID: 0029743580     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Woeber KA. Iodine and thyroid disease. Med Clin North Am 1991;75:169-178.
2. Martins MC, Lima N, Knobel M, Medeiros-Neto G. Natural course of iodine-induced thyrotoxicosis (Jod Basedow) in endemic goiter area: a 5-year follow-up. J Endocrinol Invest 1989;12:239-244.
3. Galton VA, Pitt-Rivers R. The effect of excessive iodine on the thyroid of the rat. Endocrinology 1959;64:835-839.
4. Wolff J, Chaikoff IL, Goldberg RC, Meier JR. The temporary nature of the inhibitory action of excess iodide on organic iodine synthesis in the normal thyroid. Endocrinology 1949;45:504-513.
5. Mechanick JI, Davies TF. Medical management of hyperthyroidism: Theoretical and practical aspects. In: Falk SA. Thyroid disease: endocrinology, surgery, nuclear medicine and radiotherapy. New York: Raven Press; 1990:197-232.
6. Braverman LE, Ingbar SH. Changes in thyroidal function during adaptation to large doses of iodide. J Clin Invest 1963;42:1216-1231.
7. Childs DS, Keating FR, Rall JE, Williams MMD, Power MH. The effect of varying quantities of inorganic iodide (carrier) on the urinary excretion and thyroidal accumulation of radioiodine in exophthalmic goiter. J Clin Invest 1950;29:726-738.
8. Halmi NS. Thyroidal iodine transport. Vitam Horn 1961;19:133-163.
9. Shiroozu A, Inoue K, Nakashima T, et al. Defective iodide transport and normal organification of iodide in cold nodules of the thyroid. Clin Endocrinol 1981;15:411-416.
10. Wolff J, Chaikoff IL. Plasma inorganic iodide as a homeostatic regulator of thyroid function. J Biol Chem 1948;174:555-564.
11. Wolff J, Chaikoff IL. The inhibitory action of excessive iodide upon the synthesis of diiodotyrosine and of thyroxin in the normal rat. Endocrinology 1948;43:174-179.
12. Stanley MM. The direct estimation of the rate of thyroid hormone formation in man. The effect of the iodide ion on thyroid iodine utilization. J Clin Endocrinol Metab 1949;9:941-954.
13. Clemens PC, Neumann RS. The Wolff-Chaikoff effect: hypothyroidism due to iodine application [Letter]. Arch Dermatol 1989;125:705.
14. Kocher T. Uber Jodbasedow. Archiv für Klinische Chirurgie 1910;92:1166-1193. As cited in: Lividas DP, Koutras DA, Souvatzoglou A, Beckers C. The toxic effects of small iodine supplements in patients with autonomous thyroid nodules. Clin Endocrinol 1977;7:121-127.
15. Kocher T. Uber Jodbasedow. Archiv für Klinische Chirurgie 1910;92:1166-1193. As cited in: Lividas DP, Koutras DA, Souvatzoglou A, Beckers C. The toxic effects of small iodine supplements in patients with autonomous thyroid nodules. Clin Endocrinol 1977;7:121-127.
16. Kimball OP. Induced hyperthyroidism. JAMA 1925;85:1709-1710.
17. Vagenakis AG, Wang C, Burger A, Maloof F, Braverman L, Ingbar SH. Iodide-induced thyrotoxicosis in Boston. N Engl J Med 1971;287:523-527.
18. Ermans AM, Camus M. Modifications of thyroid function induced by chronic administration of iodide in the presence of autonomous thyroid tissue. Acta Endocrinol 1976;70:463-475.
19. Field JB, Larsen PR, Yamashita K, Mashiter K, Dekker A. Demonstration of iodide transport defect but normal iodide organification in nonfunctioning nodules of human thyroid glands. J Clin Invest 1973;52:2404-2410.
20. Thomas-Morvan C, Nataf BM, Tubiana M. In vivo and organ culture studies of thyroid proteins and hormone synthesis in human thyroid cancer tissues. Ann Radiol (Paris) 1977;20:739-742.
21. Hurley JR, Becker DV. The use of radioiodine in the management of thyroid cancer. In: Freeman LM, Weissman HS, editors. Nuclear medicine annual 1983. New York: Raven Press; 1983:329-384.
22. Paul SJ, Sisson JC. Thyrotoxicosis caused by thyroid cancer. Endocrinol Metab Clin North Am 1990;19:593-612.
23. Yoshinari M, Tokuyama T, Okamura K, Sato K, Kusuda K, Fujishima M. Iodide-induced thyrotoxicosis in a thyroidectomized patient with metastatic thyroid carcinoma. Cancer 1988;61:1674-1678.
24. Morstyn G, Campbell L, Lieschke G, et al. Treatment of chemotherapy induced neutropenia by subcutaneously administered granulocyte colony-stimulating factor with optimization of dose and duration of therapy. J Clin Oncol 1989;7:1554-1562.
25. Hammond WP, IV, Price TH, Souza LM, Dale DC. Treatment of cyclic neutropenia with granulocyte colony-stimulating factor. N Engl J Med 1989;320:1306-1311.
26. Bonilla MA, Gillio AP, Ruggeiro M, et al. Effects of recombinant human granulocyte colony-stimulating factor on neutropenia in patients with congenital agranulocytosis. N Engl J Med 1989;320:1574-1580.
27. Murthy S, Webner P, Mechanick JI, Morris JC. Clinical utility of thallium-201 scintigraphy in the follow-up of differentiated thyroid cancer [Abstract]. J Nucl Med 1994;35(suppl):167P.